Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular weight of approximately 1419 g/mol and CAS number 137525-51-0
For a long time, this medication was the only drug of its type, but in recent years, other GLP-1 agonists have been approved for both the treatment of diabetes and the treatment of obesity
However, some healthcare professionals may prescribe these off-label for weight loss
Statements Author contributions AS: Conceptualization, Visualization, Resources, Validation, Formal Analysis, Project administration, Methodology, Data curation, Writing review & editing, Funding acquisition, Writing original draft, Investigation, Supervision, Software
196 Gross, E
Daly (QUB) and A